OC-2 inhibitors are a class of chemical compounds that specifically target and inhibit the function of the enzyme known as oxidoreductase 2 (OC-2). This enzyme belongs to a broader family of oxidoreductases, which are critical in catalyzing redox reactions, typically involving the transfer of electrons between molecules. These reactions are essential for various cellular processes, including metabolism and energy production. OC-2, in particular, is thought to play a role in modulating oxidative stress and maintaining redox balance within the cell. By inhibiting OC-2, these compounds interfere with the enzyme's ability to facilitate electron transfer reactions, potentially leading to altered cellular redox states. The inhibition of OC-2 can therefore influence various pathways that are reliant on the maintenance of oxidative balance, impacting processes such as mitochondrial function, cellular respiration, and the generation of reactive oxygen species (ROS).
Chemically, OC-2 inhibitors are characterized by their ability to bind selectively to the active site of the OC-2 enzyme, often through interactions with key amino acid residues involved in the catalytic process. These interactions are usually mediated by specific structural motifs within the inhibitor molecules, such as hydrophobic domains or heterocyclic rings, which provide a high degree of affinity and specificity for OC-2. The structure-activity relationships (SAR) of these compounds are of significant interest to chemists and biochemists alike, as they provide insight into how molecular modifications can enhance inhibitory potency, selectivity, and stability. Understanding the binding mechanisms and structural features that define OC-2 inhibitors is crucial for advancing the knowledge of redox biology and the chemical principles underlying enzyme inhibition. These insights may also guide the development of more efficient inhibitors that can serve as valuable tools for probing the physiological roles of OC-2 and related oxidoreductases.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
A BET bromodomain inhibitor that can indirectly affect transcription factors like OC2 by modulating chromatin accessibility and gene expression. | ||||||
GSK 525762A | 1260907-17-2 | sc-490339 sc-490339A sc-490339B sc-490339C sc-490339D | 5 mg 10 mg 50 mg 100 mg 1 g | $300.00 $540.00 $940.00 $1680.00 $5900.00 | ||
Another BET inhibitor, it may influence OC2 activity indirectly through epigenetic regulation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
A histone deacetylase (HDAC) inhibitor, which can alter chromatin structure and potentially affect OC2-mediated transcription. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
A DNA methyltransferase inhibitor, potentially affecting OC2 function by altering DNA methylation and gene expression. | ||||||
(–)-Nutlin-3 | 675576-98-4 | sc-222086 sc-222086A | 1 mg 5 mg | $120.00 $215.00 | 2 | |
Targets p53-MDM2 interaction, potentially affecting OC2-related pathways in cancer. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
A CDK4/6 inhibitor, could influence cell cycle-related pathways and indirectly impact OC2 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, might modulate signaling pathways relevant to OC2's role in cancer and development. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
A ROCK inhibitor, could influence cytoskeletal dynamics and related pathways affecting OC2 function. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
A γ-secretase inhibitor, might impact Notch signaling, potentially influencing OC2 activity in development and cancer. | ||||||